{"title":"Role of mood stabilizers in bipolar disorder.","authors":"Zubin Bhagwagar, Guy M Goodwin","doi":"10.1586/14737175.2.2.239","DOIUrl":null,"url":null,"abstract":"<p><p>Bipolar affective disorder is a common severe illness which is associated with a significant morbidity and mortality. The area of pharmacotherapy for bipolar disorders is an exciting one with a number of recent new developments. This article summarises the current state of evidence regarding the efficacy of lithium, valproate and carbamazepine for the treatment of bipolar disorders and also highlights the emerging role of the atypical antipsychotics and newer anticonvulsants.</p>","PeriodicalId":12190,"journal":{"name":"Expert Review of Neurotherapeutics","volume":"2 2","pages":"239-48"},"PeriodicalIF":3.4000,"publicationDate":"2002-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1586/14737175.2.2.239","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Neurotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1586/14737175.2.2.239","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 5
Abstract
Bipolar affective disorder is a common severe illness which is associated with a significant morbidity and mortality. The area of pharmacotherapy for bipolar disorders is an exciting one with a number of recent new developments. This article summarises the current state of evidence regarding the efficacy of lithium, valproate and carbamazepine for the treatment of bipolar disorders and also highlights the emerging role of the atypical antipsychotics and newer anticonvulsants.
期刊介绍:
Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer''s and Parkinson''s.
Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:
Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results
Article Highlights – an executive summary of the author’s most critical points